Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000550910 | SCV000654797 | likely benign | Immunodeficiency, common variable, 10 | 2025-01-26 | criteria provided, single submitter | clinical testing | |
Center for Genomics, |
RCV000550910 | SCV002495865 | uncertain significance | Immunodeficiency, common variable, 10 | 2021-07-20 | criteria provided, single submitter | clinical testing | NFKB2 NM_001077494.3 intron 18 c.2072-3C>T:This variant has not been reported in the literature but is present in 0.1% (113/68016) of European alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/10-102401177-C-T?dataset=gnomad_r3). This variant is present in ClinVar (Variation ID:474780). Evolutionary conservation and computational predictive tools for this variant are limited or unavailable. This variant is an intronic variant with no predicted change in the amino acid sequence but may have an unknown effect on splicing. Computational prediction tools for splicing are unclear. However, further studies are needed to understand its impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Ce |
RCV003424142 | SCV004127274 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | NFKB2: BP4, BS1 |
ARUP Laboratories, |
RCV000550910 | SCV005878203 | likely benign | Immunodeficiency, common variable, 10 | 2024-07-17 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003925698 | SCV004739477 | likely benign | NFKB2-related disorder | 2019-05-08 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |